Infectious Disease Control APAC News & Press Release Distribution

Infectious Disease Control

All
Global

JOYSBIO HAS DEVELOPED NEW MONKEYPOX RAPID TESTS

JOYSBIO, one of the world's leading manufacturers of rapid test kits, has developed two new Monkeypox tests that deliver results in 15 minutes TIANJIN, China, Aug. 17, 2022 /PRNewswire/ -- JOYSBIO, one of the world's leading manufacturers of lateral flow rapid test kits, is proud to announce the...

2022-08-17 14:30 4379

Novavax Nuvaxovid™ COVID-19 Vaccine Approved in South Korea for Use in Adolescents Aged 12 Through 17

* Novavax and partner SK bioscience will provide the first protein-based COVID-19 vaccine approved for use in adolescents aged 12 through 17 years in South Korea GAITHERSBURG, Md., Aug. 12, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and co...

2022-08-12 21:39 11426

FRONTIER BIOTECHNOLOGIES ANNOUNCES POSITIVE PHASE 1 RESULTS OF ITS FIRST CORONAVIRUS MAIN PROTEASE (MPRO) SMALL MOLECULE INHIBITOR, LAYING FOUNDATION FOR THE TREATMENT OF ACUTE AND LONG COVID

* FB2001 (Bofutrelvir) is a Coronavirus Mpro inhibitor, which exhibited potent anti-SARS-CoV-2 activityin vitro and in vivo * Phase 1 results show FB2001 to be generally safe and well tolerated. No significant difference was observed between Chinese and American populations. Single-agent anti...

2022-08-09 00:00 3914

FRONTIER BIOTECHNOLOGIES ANNOUNCES POSITIVE PHASE 1 RESULTS OF ITS FIRST CORONAVIRUS MAIN PROTEASE (MPRO) SMALL MOLECULE INHIBITOR, LAYING FOUNDATION FOR THE TREATMENT OF ACUTE AND LONG COVID

Catalytic Investment to Improve Community Health Care for Millions Across Africa

The Global Fund collaborates with the Johnson & Johnson Foundation and the Skoll Foundation to Launch the Africa Frontline First Catalytic Fund * Private sector investments to the Global Fund's Africa Frontline First Catalytic Fund from the Johnson & Johnson Foundation and the Skoll Foundation ...

2022-08-08 19:07 2511

ECOLAB NAMES GREGORY LUKASIK SENIOR VICE PRESIDENT AND MARKET HEAD FOR SOUTHEAST ASIA

SINGAPORE, Aug. 5, 2022 /PRNewswire/ -- Ecolab Inc., the global leader in water, hygiene and infection prevention solutions and services, namedGregory Lukasik senior vice president and market head forSoutheast Asia.

2022-08-05 09:00 9602

ECOLAB NAMES GREGORY LUKASIK SENIOR VICE PRESIDENT AND MARKET HEAD FOR SOUTHEAST ASIA

Vela Diagnostics Supports COVID-19 Surveillance Efforts in Kenya

HAMBURG, Germany, Aug. 3, 2022 /PRNewswire/ -- Vela Diagnostics has announced its appointment by the National Public Health Laboratory ofKenya (NPHL) as their supplier for SARS-CoV-2 genotyping tests, with funding from The Global Fund. The NPHL operates under Kenya's Ministry of Health and plays...

2022-08-03 14:00 2698

Novel and fast typing method developed to control monkeypox by Molecular Biology Systems (MBS) in collaboration with the Amsterdam UMC and Danish Rigshospitalet

GOES, Netherlands, Aug. 2, 2022 /PRNewswire/ -- In the worldwide effort to control monkeypox, a novel and fast typing method to trace monkeypox virus strains was developed by Dutch company Molecular Biology Systems (MBS) in collaboration with the department of Medical Microbiology & Infectious Di...

2022-08-02 08:00 3035

PERSISTENT LOSS OF SMELL DUE TO COVID-19 CLOSELY CONNECTED TO LONG-LASTING COGNITIVE PROBLEMS

FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2022 Also, ICU Stay May Double Risk of Dementia in Older Adults SAN DIEGO, Aug. 1, 2022 /PRNewswire/ -- New insights into factors that may predict, increase or protect against the impact of COVID-19 and the pandemic on memory and thinkin...

2022-08-01 09:03 3572

Global Fund Reports Significant Progress in Breaking Down Human Rights-Related Barriers to HIV and TB Services

MONTREAL, Aug. 1, 2022 /PRNewswire/ -- A new report released by the Global Fund today at the 24th International AIDS Conference unveils key findings of the activities supported by the G...

2022-08-01 08:59 2375

Brii Biosciences Announces Positive Data Demonstrating its Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, Retains Neutralizing Activity Against Live Omicron Virus BA.4/5 and BA.2.12.1 Subvariants

Independent lab results demonstrate that the combination therapy retains neutralizing activity against currently dominant COVID-19 strains, as previously demonstrated with all variants of concern to date The amubarvimab/romlusevimab combination is commercially available in China and is under rev...

2022-07-27 07:00 4240

Novavax Announces Expanded Approval of Nuvaxovid™ COVID-19 Vaccine for Adolescents Aged 12 through 17 in Japan

* Nuvaxovid™ is the first protein-based COVID-19 vaccine approved for use in adolescents inJapan GAITHERSBURG, Md., July 26, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious d...

2022-07-26 20:05 3134

Vaccines alone aren't enough to combat AMR, claims new WHO report

The Global Hygiene Council (GHC) calls for the use of hygiene practices, such as handwashing, alongside vaccinations to prevent the spread of infectious diseases and reduce the impact of antimicrobial resistance (AMR). LONDON, July 23, 2022 /PRNewswire/ -- A recent report

2022-07-23 00:30 9327

VIRALEZE™ Nasal Spray Protects Against Highly Infectious Omicron in Viral Challenge Model - Before or After Viral Exposure

MELBOURNE, Australia, July 20, 2022 /PRNewswire/ -- Starpharma's broad-spectrum VIRALEZE™ nasal spray has shown protection against infection with the highly transmissible SARS-CoV-2 Omicron variant in a stringent viral challenge model. VIRALEZE™ is a broad-spectrum barrier nasal spray, developed ...

2022-07-20 17:45 2618

U.S. CDC Advisory Committee Unanimously Recommends Novavax COVID-19 Vaccine, Adjuvanted as a Primary Series for Individuals Aged 18 and Older

* Recommendation follows U.S. FDA Emergency Use Authorization for the Novavax COVID-19 Vaccine, Adjuvanted as a two-dose primary series * FDA has determined that first vaccine lot has met all release specifications and is acceptable for use underEmergency Use Authorization * Novavax expects ...

2022-07-20 05:46 3430

Seegene launches world's first In-life PCR campaign in Vietnam

* Test center LabHouse and ride-hailing service Grab to start PCR testing for Grab drivers in August * Seegene to provide Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay to simultaneously detect COVID-19, flu, cold * Testing to begin with drivers in Ho Chi Minh, Hanoi and will later be expanded to ...

2022-07-19 18:43 2473

Brii Bio Announces Strategic Partnership with China Resources Pharmaceutical Commercial Group to Advance the Commercialization of Long-acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, in China

The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China The amubarvimab/romlusevimab combination is the first locally-discovered and approved SARS-CoV-2 target-specific treatment inChina, evaluated through a rand...

2022-07-19 12:34 4843

Zymo Research's DNA/RNA Shield™ Inactivates Monkeypox for the Collection and Transportation of Samples

IRVINE, Calif., July 15, 2022 /PRNewswire/ -- Zymo Research Corp., in collaboration with the Institute of Virology, University Medical Center Freiburg,Germany, demonstrated data showing their DNA/RNA Shield™ Inactivating Transport Medium (ITM) completely inactivated recent Monkeypox virus isolate...

2022-07-15 06:42 4598

Zymo Research's DNA/RNA Shield™ Inactivates Monkeypox for the Collection and Transportation of Samples

U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted for Individuals Aged 18 and Over

* Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S. * Immunizations with the Novavax COVID-19 Vaccine, Adjuvanted as a primary series will begin upon product release and once a policy recommendation from the CDC is received GAITHERSBURG, Md., July 14, 2022 /P...

2022-07-14 06:06 4162

Glenmark Pharmaceuticals and SaNOtize Announce Peer Reviewed Publication of Its Phase 3 Clinical Trials on SaNOtize's Novel Nitric Oxide Nasal Spray for COVID-19 in Lancet Journal

MUMBAI, India and VANCOUVER, BC, July 13, 2022 /PRNewswire/ -- Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven, global pharmaceutical company and SaNOtize Research and Development Corp, today announced thatThe Lancet Regional Health Southeast Asia (TLRHSEA) – peer reviewed, high...

2022-07-13 20:06 3830

Brii Biosciences Appoints Dr. Susannah Cantrell as Chief Business Officer

Strategic executive hire adds to Company's global leadership team and positions the Company for continued growth DURHAM, N.C.and BEIJING, July 13, 2022 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national...

2022-07-13 19:00 3899

1 ... 9 10 111213 14 15 ... 29